PURPOSE: Botulinum A toxin (BoNT-A) injections are used widely to manage lower
extremity spasticity in children with cerebral palsy. However, their use in the upper extremity …

This study compared clinical and functional outcomes after treatment with botulinum toxin A
(BTX-A) and BTX-A with casting in children with dynamic equinus foot. Ten children (seven …

Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin
type A and occupational therapy in the upper limbs of children with cerebral palsy: a …

The aim of this article was to present a review of the research literature on the outcome of
botulinum toxin type A (BTX-A) injection for management of upper limb spasticity in children …

Spastic diplegia is a severely disabling condition and many current treatment options offer
the patient no real therapeutic benefit. Intramuscular injection of botulinum toxin type A (BTX …

BACKGROUND: Dystonia and spasticity are common symptoms in children with Cerebral
Palsy (CP), whose management is a challenge to overcome in order to enable the …

The aim of this review was to assess the effectiveness of therapy interventions on improving
outcomes in children with cerebral palsy (CP) who have received botulinum toxin A (BTX-A) …

This study evaluated the efficacy and safety of three doses of botulinum toxin A (BTX-A;
Dysport®) in 125 patients (mean age 5.2 years, SD 2; 54% male) with dynamic equinus …

Objective This study aimed to evaluate the effects of botulinum toxin A (BTX-A) treatment on
energy expenditure and ambulation in children with cerebral palsy (CP) and to determine if …

In this study, we compared the long‐term efficacy and tolerability of two dosage regimens of
the potent botulinum toxin type A (BoNT‐A; Dysport; Ipsen Ltd, Slough, UK) in children with …